fbpx

Latest News

Article Published in the MLO in the USA Shows the Benefit of Plasma Viscosity Testing for COVID-19

An article published recently in the MLO in the USA adds further evidence to the benefits of using plasma viscosity testing when managing patients suffering from COVID-19. It follows on from the study published by Addenbrookes Hospital in Cambridge earlier this year.

With the growing body of evidence for the use of plasma viscosity testing for managing COVID-19, now is the time to explore how our clinical viscometers can help healthcare professionals to better utilise their resources during the pandemic.

Click here to see the article

 

More News

Biomedical Scientist from Addenbrookes wins the 2021 Bernie Benson Award for Research into Plasma Viscosity and COVID-19.

We are pleased to announce that the 2021 winner is Daniel Gleghorn from Addenbrookes Hospital in Cambridge. We were looking...

Read More

Strongest Evidence Yet of the Diagnostic Value of Plasma Viscosity Testing in the Risk Stratification of Patients with COVID‐19

A paper published on April 4th 2021 in International Journal of Laboratory Hematology has shown the strongest evidence yet of...

Read More

Bernie Benson Award 2021

Call for Nominations for the Bernie Benson Award 2021 Nominate someone in your lab who has achieved outstanding progression in...

Read More